Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Change in Receivables (2024 - 2025)

Historic Change in Receivables for Neuphoria Therapeutics (NEUP) over the last 2 years, with Q4 2025 value amounting to $1.1 million.

  • Neuphoria Therapeutics' Change in Receivables rose 147831.32% to $1.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 million, marking a year-over-year change of. This contributed to the annual value of -$114936.0 for FY2025, which is 6158.59% up from last year.
  • Latest data reveals that Neuphoria Therapeutics reported Change in Receivables of $1.1 million as of Q4 2025, which was up 147831.32% from -$10190.0 recorded in Q3 2025.
  • Over the past 5 years, Neuphoria Therapeutics' Change in Receivables peaked at $1.1 million during Q4 2025, and registered a low of -$80399.0 during Q4 2024.